Literature DB >> 20728767

Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.

Benjamin M Craig1, Marc Brisson, Harrell Chesson, Anna R Giuliano, Mark Jit.   

Abstract

BACKGROUND: Prominent published and active human papillomavirus (HPV) modelers from around the world were invited to participate in the inaugural Modeling Evidence in HPV (MEHPV) Pre-Conference Workshop on May 9-10, 2009, in Malmö, Sweden. The workshop took place directly before the 25th International Papillomavirus Conference.
OBJECTIVES: The aim of the workshop was to develop an international network of investigators engaged in HPV modeling and to facilitate open discussion about the structure and parameterization of models, as well as other methodologic concerns.
METHODS: Thirty-four participants from more than a dozen countries and a variety of settings, representing the authors or coauthors of 82% of the HPV modeling literature, exchanged ideas on fundamental questions in the field. These proceedings, based on the 217-page transcript, were assembled by the Scientific Committee to summarize the ideas of workshop participants in a deidentified, readable fashion. They represent the work and recorded opinions of session participants and do not constitute the official positions of participants as a whole or individually, the Scientific Committee, or any sponsoring organization or entity.
RESULTS: In charting a path forward, 3 topics emerged as most pressing: best practices for HPV modeling, comparative modeling, and modeling in developing countries.
CONCLUSION: This summary of the proceedings of the preconference workshop on HPV modeling characterizes many of the prominent contemporary issues in the field. 2010 Excerpta Medica Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728767      PMCID: PMC4095755          DOI: 10.1016/j.clinthera.2010.06.017

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  20 in total

1.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

2.  Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000.

Authors:  E Kathleen Adams; Nancy Breen; Peter J Joski
Journal:  Cancer       Date:  2007-01-15       Impact factor: 6.860

3.  Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

Authors:  Lauri E Markowitz; Maya Sternberg; Eileen F Dunne; Geraldine McQuillan; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

4.  Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

Authors:  Sue J Goldie; Jane J Kim; Thomas C Wright
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

5.  Human papillomavirus infection and cervical cancer prevention in Japan and Korea.

Authors:  Ryo Konno; Hai-Rim Shin; Young-Tak Kim; Yong Sang Song; Toshiyuki Sasagawa; Masaki Inoue; Jong-Sup Park
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

6.  HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.

Authors:  G Y Ho; A S Kadish; R D Burk; J Basu; P R Palan; M Mikhail; S L Romney
Journal:  Int J Cancer       Date:  1998-10-29       Impact factor: 7.396

7.  Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.

Authors:  Salvatore Vaccarella; Rolando Herrero; Peter J F Snijders; Min Dai; Jaiye O Thomas; Nguyen Trong Hieu; Catterina Ferreccio; Elena Matos; Hector Posso; Silvia de Sanjosé; Hai Rim Shin; Sukhon Sukvirach; Eduardo Lazcano-Ponce; Nubia Muñoz; Chris J L M Meijer; Silvia Franceschi
Journal:  Int J Epidemiol       Date:  2008-03-03       Impact factor: 7.196

8.  Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.

Authors: 
Journal:  Diabetes Care       Date:  2007-06       Impact factor: 19.112

9.  The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.

Authors:  G Bigras; F de Marval
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

Review 10.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

View more
  3 in total

Review 1.  Systematic review of model-based cervical screening evaluations.

Authors:  Diana Mendes; Iren Bains; Tazio Vanni; Mark Jit
Journal:  BMC Cancer       Date:  2015-05-01       Impact factor: 4.430

2.  Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Authors:  Mark Jit; Carol Levin; Marc Brisson; Ann Levin; Stephen Resch; Johannes Berkhof; Jane Kim; Raymond Hutubessy
Journal:  BMC Med       Date:  2013-01-30       Impact factor: 8.775

3.  HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control.

Authors:  Karen Canfell; Jane J Kim; Shalini Kulasingam; Johannes Berkhof; Ruanne Barnabas; Johannes A Bogaards; Nicole Campos; Chloe Jennett; Monisha Sharma; Kate T Simms; Megan A Smith; Louiza S Velentzis; Marc Brisson; Mark Jit
Journal:  Papillomavirus Res       Date:  2019-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.